ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1564	National Cancer Institute	Html	en	Laryngeal Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of laryngeal cancer.	treatment 0.456448 cancer treatment 0.208981 vocal cords 0.463035 Laryngeal Cancer Treatment 0.208444 NCI-supported cancer 0.201905 cancer cells 0.32099 stage laryngeal cancer 0.221553 body 0.20156 chemotherapy 0.227934 PDQ cancer information 0.235798 larynx 0.286996 clinical trial search 0.245354 Hyperfractionated radiation therapy 0.214818 laryngeal cancer spreads 0.200731 National Cancer Institute 0.254821 laryngeal cancer 0.644668	clinical trials 0.596105 metastatic laryngeal cancer 0.202273 cancer information summary 0.213869 clinical trial 0.439358 Recurrent laryngeal cancer 0.222324 new treatment 0.207333 patients 0.231814 neck 0.206846 original tumor 0.252057 cancer clinical trials 0.262761 stage 0.247854 lymph nodes 0.238789 lymph node 0.41143 radiation therapy 0.83207 cancer 0.992267	CLICK HERE
1665	National Cancer Institute	Html	null	Last Days of Life (PDQ®)–Patient Version	Expert-reviewed information summary about care during the last days to last hours of life, including common symptoms, ethical dilemmas that may arise, and the role of the oncologist in caring for patients and their families during this time.			CLICK HERE
1689	National Cancer Institute	Html	en	Childhood Central Nervous System Germ Cell Tumors Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of childhood central nervous system germ cell tumors.	craniospinal irradiation 0.568926 intracranial germinoma 0.542559 survival rates 0.505415 excellent survival rates 0.497286 endodermal sinus tumor 0.492396 germ cell tumor 0.543477 chemotherapy 0.510034 reduced-volume radiation therapy 0.492394 ifosfamide based chemotherapy 0.484152 Tumors Treatment Overview 0.506029 primordial germ cells 0.489907 focal radiation therapy 0.518434 pure germinomas 0.484971 Radiat Oncol Biol 0.492523 tumor markers 0.56413 radiation therapy doses 0.490668 CNS germ cell 0.55586 tumor markers AFP 0.505621 cerebrospinal tumor markers. 0.502663 conventional whole-brain irradiation 0.482504 whole-ventricular radiation therapy 0.492409 CSF AFP levels 0.509387 nongerminomatous germ cell 0.513106 cell tumor study 0.490435 yolk sac tumor 0.491117	germ cell theory 0.506108 common solid tumor 0.502347 germinomatous germ cell 0.4915 primary chemotherapy 0.487412 radiation therapy 0.751812 et al. 0.485468 Low-dose craniospinal irradiation 0.484891 CNS GCTs 0.523584 whole-ventricle radiation therapy 0.491449 SIOP CNS GCT 0.490345 brain tumor treatment 0.516207 primary brain tumors 0.544753 neoadjuvant chemotherapy results 0.491554 Pediatr Blood Cancer 0.568832 response-based radiation therapy 0.486149 radiation treatment volume 0.488339 boost radiation therapy 0.486976 nervous system tumors 0.483298 Brain Tumor Study 0.49693 Oncol Biol Phys 0.49429 specific chemotherapy regimen 0.484857 intracranial germ cell 0.58985 germ cell tumors 0.911962 radiation therapy fields 0.485192	CLICK HERE
1941	National Cancer Institute	Html	es	La espiritualidad en el tratamiento del cáncer (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca de la influencia que tiene la espiritualidad y la religión en las personas que tienen cáncer. Se discuten varios métodos sobre manejo e intervención.	Illness Therapy—Spiritual Well-Being 0.364147 Koenig HG 0.516168 with breast 0.448622 with medical care 0.377932 Coping with breast 0.377717 among patients with 0.376638 religious involvement 0.469162 coping with 0.537521 religious coping 0.832653 longitudinal study 0.375646 Natl Med Assoc 0.392743 psychological distress 0.369731 Spillers RL 0.367074 palliative care consultation 0.388149 Sin embargo 0.391017 Psychiatry Med 0.42361 spiritual needs 0.450941 Balboni TA 0.366785 satisfaction with care 0.45185 among persons with 0.418188 patients with 0.768654 Religious Coping Scale 0.480675 Pargament KI 0.627933 Larson DB 0.403043 Tarakeshwar N 0.414441	Olver IN 0.377185 Care Cancer 0.680736 palliative care 0.405966 meet spiritual needs 0.420651 spiritual well-being among 0.364926 Vanderwerker LC 0.413553 mortality among medically 0.373039 spiritual well-being 0.567991 Consult Clin Psychol 0.378631 New York 0.37969 Intern Med 0.421384 Spiritual Intervention Study 0.363114 Palliat Med 0.935675 Clin Oncol 0.573043 Spiritual Well-Being Scale 0.362892 Cancer Surviv 0.366225 Arch Intern Med 0.39787 with metastatic breast 0.403978 spirituality as predictors 0.390155 spiritual care 0.472279 ill elderly patients 0.379545 chronic illness 0.365965 spiritual support among 0.431243 associations with 0.43557	CLICK HERE
1958	National Cancer Institute	Html	es	Tratamiento del retinoblastoma (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del retinoblastoma en niños.	siguientes procedimientos 0.348249 células madre 0.681334 células madre ayuda 0.327411 pequeña cantidad 0.314739 quimioterapia regional.También 0.356888 siguientes especialistas 0.315369 rayos x 0.316905 huesos.ampliar exploración 0.316446 sección información 0.311156 ondas sonoras 0.352613 efectos tardíos 0.419814 PDQ Efectos tardíos 0.340519 estadio iva 0.318526 tejidos cercanos.ampliar radioterapia 0.346215 quimioterapia sistémica 0.959376 líquido cefalorraquídeo 0.342894 National Cancer Institute 0.310552	retinoblastoma causa efectos 0.427797 estadios iiia 0.316715 Instituto Nacional 0.318729 PDQ Tratamiento 0.331936 determinados cambios 0.322309 International Retinoblastoma Staging 0.571406 Drugs Approved 0.312346 gen rb1 0.821065 Physician Data Query 0.339103 sistema nervioso central 0.324254 posibles efectos 0.313593 Retinoblastoma Staging System 0.572567 siguientes situaciones 0.322957 placa ayuda 0.311711 haz láser 0.317188 siguientes pruebas 0.320835	CLICK HERE
2030	National Cancer Institute	Html	es	Exámenes de detección del cáncer de seno (mama) (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre pruebas que se usan para detectar el cáncer de mama.	carcinoma in situ 0.428206 Surgical Adjuvant Breast 0.33856 Breast Screening Study-2 0.364743 cohort with breast 0.321173 Breast Cancer Surveillance 0.36101 American Cancer Society 0.380459 ductal proliferative breast 0.324288 ductal carcinoma in 0.430875 breast biopsy 0.352636 Elmore JG 0.344418 Swedish two-county breast 0.320934 Breast Screening 0.503535 Breast Screening Study 0.375642 Rosenberg RD 0.33024 Kerlikowske K 0.327142 Nelson HD 0.325559 Canadian National Breast 0.417726 Individual Breast Biopsy 0.343511 evaluación bi-rads 0.320008 Scotia Breast Screening 0.356932 breast pathology 0.332437 Estados Unidos 0.485991 screening mammograms 0.346351 Natl Cancer Inst 0.674282 Breast tumor characteristics 0.346186	mamografía detecta 0.320239 breast self-examination 0.321577 screening mammographic sensitivity 0.338051 National Breast Screening 0.456899 mamografía digital versus 0.325297 Breast Screening Program 0.356597 modern screening mammography 0.338726 Cancer Facts 0.328174 breast cancers 0.931042 Image-detected breast 0.320721 Breast Imaging Reporting 0.320397 screening mammography 0.509779 Breast Biopsy Slides 0.344265 screening trial 0.341724 mammographic screening 0.329483 Carney PA 0.325142 Intern Med 0.487403 Breast symptoms among 0.322392 Arch Intern Med 0.323503 clinical breast 0.339712 mammographic screening from 0.319885 in situ 0.62536 Cancer Surveillance Consortium 0.332496 Nova Scotia Breast 0.339428	CLICK HERE
2115	National Cancer Institute	Html	es	Prevención del cáncer de hígado (hepatocelular) (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre factores que influirían en el riesgo de presentar cáncer hepatocelular y sobre las investigaciones dirigidas a la prevención de esta enfermedad.	chronic hepatitis b 0.391786 chronic hepatitis c 0.392121 available online 0.329517 American Cancer Society 0.362594 tt virus dna 0.321147 largo plazo 0.314356 with hepatocellular carcinoma 0.362577 hepatitis e 0.456465 CHC agudo 0.334135 denominación hepatitis no-A 0.402257 hepatocellular carcinoma 0.818192 Concurrent hepatitis 0.385001 Instituto Nacional 0.321684 Qidong hepatitis 0.385791 patients with chronic 0.340288 hígado llamada cirrosis 0.31992 hepatitis nanb 0.397414 risk factors 0.334046 hepatitis b 0.815878 hepatitis c 0.64216 Estados Unidos 0.516836 virus hepáticos forma 0.324783 Universal hepatitis 0.404867 Spanish patients with 0.316748 PDQ Prevención 0.319178	patients with 0.420437 carcinoma among patients 0.322468 SEER Cancer Statistics 0.314302 Rizzetto M 0.316034 Infect Dis 0.316615 virus carriers with 0.326772 natural history 0.314507 Ningún virus 0.321223 hepatocelular factores causales 0.320088 Viral Hepatitis FAQs 0.396943 National Cancer Institute 0.335176 La hepatitis 0.94804 Chang MH 0.316907 viral hepatitis 0.515061 Yuan JM 0.316452 GB virus 0.317604 correlate with expression 0.314623 Long-term phlebotomy with 0.314798 Liver Int 0.354023 Hepatocellular carcinoma without 0.326846 chronic hepatitis 0.450334 hepatitis aguda 0.53174 hepatitis tipos 0.394509 virus rna 0.317794	CLICK HERE
17190	National Cancer Institute	Html	en	Fertility Issues in Girls and Women with Cancer	Fertility issues are common in women getting cancer treatment. Fertility preservation options include egg freezing, embryo freezing, ovarian tissue freezing, ovarian shielding and ovarian transposition. Resources, support, and clinical trials are listed.	Sexual Health Issues 0.49945 cancer treatment 0.631654 fertility 0.901077 fertility option 0.589889 baseline fertility 0.607588 primary ovarian insufficiency 0.602729 health care team 0.580901 fertility problems 0.587938 stem cell transplants 0.556421 Child Health 0.492531 upsetting long-term effects 0.489052 nearby lymph nodes 0.481626 Bone marrow transplants 0.488319 fertility clinic 0.591948 nearby reproductive organs 0.498052 professionally led support 0.48644 fertility options 0.611153 Egg freezing 0.48771 female cancer patients 0.5846 radiation therapy 0.529983 hot flashes 0.502166 body receiving radiation 0.494041 menstrual periods 0.491262 vaginal dryness 0.507499 early-stage cervical cancer 0.50324	cancer treatments 0.607491 night sweats 0.503968 young female cancer 0.581679 ovaries 0.50886 embryo freezing 0.490634 blood stem cell 0.486791 personal health factors 0.498007 fertility return 0.579732 fertility preservation options 0.694907 fertility preservation 0.7168 ovarian shielding 0.508485 National Institute 0.498573 fertility risks 0.557024 Human Development 0.498529 Reproductive medical information 0.494403 LIVESTRONG Fertility 0.567758 fertility specialist 0.619863 Ovarian tissue freezing 0.511454 cancer 0.694555 fertility preservation clinic 0.610485 fertility preservation discounts 0.595763 ovarian tissue 0.520736 ovarian tissue cryopreservation 0.503109 nearby reproductive tissues 0.497596	CLICK HERE
17242	National Cancer Institute	Html	en	National Cryo-Electron Microscopy Facility Team Members	The National Cryo-Electron Microscopy Facility team is responsible for the operational activities of NCEF. Find team member bios and a list of NCEF working group members.	strategic oversight 0.549362 Lab Advisory Committee 0.88433 Frederick National Lab 0.883241 NCEF Senior Microscopist 0.757617 Molecular Virology 0.5561 government contract projects 0.639164 cancer researchers. 0.551348 Piermaria J. Oddone 0.648956 Thomas Edwards 0.534246 cryo-EM laboratories 0.7289 Grant J. Jensen 0.61562 advisory committee members 0.653176 research expertise 0.57237 PMP certification 0.536505 structural biology 0.656766 Advanced Computer Studies 0.527736 L. Mario Amzel 0.617619 NCEF Scientific Project 0.683141 Biophysics Section 0.560804 Stephen C. Harrison 0.611643 structural studies 0.552951 resolution cryo-electron microscopy 0.682528 structural biology communities 0.646732 academic research 0.551259 Hopkins University School 0.630222	Steven J. Ludtke 0.641874 cryo-EM services 0.763943 Senior Investigator 0.530394 Physical Biochemistry 0.552108 Infectious Disease research 0.655231 Sriram Subramaniam 0.554662 Angela M. Gronenborn 0.615627 Ph.D 0.61505 Hong Zhou 0.531963 core team 0.649969 structural analysis 0.55203 Ulrich Baxa 0.572356 Edward H. Egelman 0.618207 Cancer Research 0.549211 NCEF Microscopist 0.616796 National Lab Advisory 0.882693 adjunct faculty appointments 0.637399 strong background 0.529367 Cell Biology 0.534261 Project Management 0.649065 National Cryo-EM Facility 0.904008 Helen Wang 0.529981 single particle cryo-EM 0.833864 electron tomography 0.5462	CLICK HERE
17285	National Cancer Institute	Html	en	Cognitive Impairment in Adults with Non?Central Nervous System Cancers (PDQ®)–Health Professional Version	Expert-reviewed information summary about cognitive impairment in cancer patients versus normal cognition, and interventions to manage cognition changes	baseline cognitive reserve 0.507261 Cognitive changes 0.487133 adjuvant chemotherapy 0.565287 cancer treatment 0.487264 female breast cancer 0.505802 healthy control subjects 0.489493 Evidence-based cognitive rehabilitation 0.50091 Primary Breast Cancer 0.514885 Advanced cognitive training 0.507364 Clin Breast Cancer 0.579754 cognitive disturbance 0.483538 therapy-related cognitive deficits 0.504332 Eur J Cancer 0.484911 early-stage breast cancer 0.528107 cognitive dysfunction 0.521546 Von Ah 0.50591 cognitive function 0.609612 cancer-related cognitive impairment 0.500166 cognitive problems. 0.495567 breast cancer patients 0.582272 cancer patients 0.586019 elderly cancer patients 0.495074 cognitive functioning 0.510209 breast cancer survivors 0.779751 self-reported cognitive complaints 0.520137	cancer survivors 0.787075 cancer chemotherapy 0.497699 et al. 0.681052 psychosocial cancer rehabilitation 0.489752 colorectal cancer survivors 0.495325 cognitive rehabilitation 0.534264 PUBMED Abstract 0.565725 Support Care Cancer 0.521007 chemotherapy-treated breast cancer 0.517795 self-reported cognitive dysfunction 0.498525 experience cognitive problems 0.520232 cognitive impairment. 0.494247 Abstract 0.636513 Clin Oncol 0.48687 breast cancer 0.95028 group cognitive rehabilitation 0.514826 elderly cancer survivors 0.500464 randomized controlled trial 0.590229 Cognitive rehabilitation group 0.513937 treatment-related cognitive impairment 0.499304 brain tumor patients 0.525127 chemotherapy-related cognitive change 0.538912 cognitive impairment 0.555272 self-reported cognitive problems 0.505428	CLICK HERE